Clinical Trial Update: Vitamin D Augmentation of Tekturna (Aliskiren) in Hypertension [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on vitamin D augmentation of aliskiren (Tekturna) for hypertension; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Tekturna (aliskiren)

Snippet

Sponsor: Wayne State University | Conditions: Hypertension | Phase 4 | Status: UNKNOWN